In addition, STAU2‐ASO treatment led to a marked STAU2 expression down‐regulation and the EMT pathway suppression in tumor tissues, confirming its potent anti‐metastatic efficacy in PDAC (Figure 8I,J). Here, STAU2 is linked to neoplasm.